| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperoxia | 24 | 2025 | 87 | 5.690 |
Why?
|
| Lung | 29 | 2025 | 380 | 5.650 |
Why?
|
| Bronchopulmonary Dysplasia | 16 | 2025 | 55 | 4.620 |
Why?
|
| Thioredoxin Reductase 1 | 8 | 2020 | 13 | 3.770 |
Why?
|
| NF-E2-Related Factor 2 | 7 | 2023 | 122 | 2.980 |
Why?
|
| Selenium | 6 | 2025 | 17 | 2.380 |
Why?
|
| Thioredoxins | 6 | 2019 | 26 | 2.300 |
Why?
|
| Epithelial Cells | 8 | 2025 | 256 | 2.100 |
Why?
|
| Aurothioglucose | 6 | 2020 | 11 | 2.010 |
Why?
|
| Lung Injury | 8 | 2023 | 32 | 1.950 |
Why?
|
| Animals, Newborn | 19 | 2025 | 181 | 1.670 |
Why?
|
| Glutathione | 10 | 2020 | 76 | 1.630 |
Why?
|
| Pulmonary Alveoli | 9 | 2021 | 33 | 1.550 |
Why?
|
| Auranofin | 3 | 2020 | 5 | 1.380 |
Why?
|
| Animals | 44 | 2025 | 10583 | 1.350 |
Why?
|
| Heme Oxygenase-1 | 3 | 2020 | 36 | 1.350 |
Why?
|
| Infant, Premature | 8 | 2023 | 144 | 1.320 |
Why?
|
| Mice | 31 | 2025 | 4735 | 1.290 |
Why?
|
| Antioxidants | 4 | 2023 | 224 | 1.230 |
Why?
|
| Oxygen | 7 | 2025 | 234 | 1.150 |
Why?
|
| Dietary Supplements | 5 | 2019 | 265 | 1.140 |
Why?
|
| Thioredoxin-Disulfide Reductase | 4 | 2020 | 14 | 1.120 |
Why?
|
| MicroRNAs | 6 | 2021 | 301 | 1.070 |
Why?
|
| Mice, Inbred C3H | 14 | 2025 | 74 | 1.060 |
Why?
|
| Infant, Newborn | 18 | 2025 | 899 | 1.060 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 633 | 1.010 |
Why?
|
| DNA Methylation | 2 | 2016 | 152 | 0.890 |
Why?
|
| Respiratory Mucosa | 3 | 2025 | 60 | 0.840 |
Why?
|
| Oxidative Stress | 6 | 2025 | 671 | 0.830 |
Why?
|
| Lung Diseases | 4 | 2019 | 43 | 0.810 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 3 | 2018 | 40 | 0.780 |
Why?
|
| Infant, Premature, Diseases | 2 | 2019 | 37 | 0.740 |
Why?
|
| Macrophages, Alveolar | 1 | 2020 | 36 | 0.660 |
Why?
|
| Air | 1 | 2020 | 23 | 0.650 |
Why?
|
| Gene Deletion | 1 | 2020 | 120 | 0.630 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2019 | 17 | 0.610 |
Why?
|
| Neovascularization, Physiologic | 1 | 2020 | 124 | 0.610 |
Why?
|
| Vascular Remodeling | 1 | 2019 | 14 | 0.600 |
Why?
|
| Sulfhydryl Compounds | 1 | 2019 | 30 | 0.600 |
Why?
|
| Reactive Oxygen Species | 3 | 2020 | 292 | 0.600 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2010 | 179 | 0.580 |
Why?
|
| Uteroglobin | 2 | 2020 | 5 | 0.580 |
Why?
|
| Promoter Regions, Genetic | 3 | 2016 | 344 | 0.580 |
Why?
|
| Carrier Proteins | 2 | 2010 | 252 | 0.550 |
Why?
|
| Infant, Extremely Premature | 1 | 2018 | 12 | 0.550 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 94 | 0.550 |
Why?
|
| Oxidants | 2 | 2020 | 31 | 0.540 |
Why?
|
| Docosahexaenoic Acids | 3 | 2015 | 106 | 0.510 |
Why?
|
| Pneumonia | 2 | 2023 | 89 | 0.510 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2014 | 39 | 0.510 |
Why?
|
| Pulmonary Artery | 2 | 2014 | 69 | 0.500 |
Why?
|
| Inflammation | 6 | 2017 | 642 | 0.490 |
Why?
|
| Mice, Inbred C57BL | 8 | 2021 | 1602 | 0.490 |
Why?
|
| Aging | 2 | 2020 | 979 | 0.480 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2020 | 128 | 0.470 |
Why?
|
| Humans | 27 | 2025 | 28585 | 0.470 |
Why?
|
| Membrane Proteins | 2 | 2018 | 485 | 0.460 |
Why?
|
| Female | 19 | 2025 | 15472 | 0.420 |
Why?
|
| Secretoglobins | 1 | 2013 | 2 | 0.420 |
Why?
|
| Annexin A1 | 1 | 2013 | 3 | 0.420 |
Why?
|
| Glutathione Reductase | 4 | 2020 | 22 | 0.410 |
Why?
|
| Glutathione Disulfide | 2 | 2012 | 14 | 0.390 |
Why?
|
| Cells, Cultured | 5 | 2025 | 1009 | 0.390 |
Why?
|
| Hypoxia | 1 | 2013 | 90 | 0.380 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 17 | 0.370 |
Why?
|
| Neutrophil Infiltration | 2 | 2010 | 19 | 0.360 |
Why?
|
| Pregnancy | 8 | 2022 | 1219 | 0.360 |
Why?
|
| Proteins | 1 | 2013 | 253 | 0.350 |
Why?
|
| Oxidation-Reduction | 4 | 2023 | 366 | 0.330 |
Why?
|
| Glutathione Peroxidase | 3 | 2020 | 26 | 0.330 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2010 | 11 | 0.330 |
Why?
|
| Disease Models, Animal | 9 | 2023 | 1494 | 0.330 |
Why?
|
| Cell Line | 4 | 2018 | 698 | 0.330 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 74 | 0.330 |
Why?
|
| Liver | 4 | 2020 | 456 | 0.330 |
Why?
|
| Signal Transduction | 6 | 2020 | 1455 | 0.320 |
Why?
|
| Cell Proliferation | 1 | 2013 | 817 | 0.320 |
Why?
|
| Vasodilator Agents | 3 | 2019 | 79 | 0.320 |
Why?
|
| Nitric Oxide | 3 | 2020 | 152 | 0.310 |
Why?
|
| Transcription, Genetic | 3 | 2020 | 404 | 0.300 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2019 | 23 | 0.300 |
Why?
|
| RNA, Messenger | 5 | 2019 | 667 | 0.300 |
Why?
|
| Ozone | 2 | 2019 | 5 | 0.300 |
Why?
|
| Macrophages | 3 | 2020 | 302 | 0.290 |
Why?
|
| Iron | 3 | 2018 | 117 | 0.290 |
Why?
|
| Nitrogen Oxides | 2 | 2018 | 41 | 0.280 |
Why?
|
| Antirheumatic Agents | 2 | 2018 | 57 | 0.270 |
Why?
|
| Lipopolysaccharides | 5 | 2020 | 157 | 0.250 |
Why?
|
| RNA, Long Noncoding | 2 | 2016 | 32 | 0.240 |
Why?
|
| Male | 12 | 2020 | 13772 | 0.240 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 251 | 0.230 |
Why?
|
| Cyclooxygenase 2 | 4 | 2013 | 68 | 0.230 |
Why?
|
| Body Weight | 4 | 2016 | 250 | 0.220 |
Why?
|
| Apoptosis | 2 | 2020 | 777 | 0.220 |
Why?
|
| Proteomics | 1 | 2025 | 192 | 0.210 |
Why?
|
| Vasodilation | 3 | 2019 | 115 | 0.210 |
Why?
|
| Mice, Knockout | 2 | 2018 | 862 | 0.200 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2016 | 126 | 0.200 |
Why?
|
| Multicenter Studies as Topic | 2 | 2021 | 47 | 0.200 |
Why?
|
| Cell Differentiation | 1 | 2025 | 419 | 0.200 |
Why?
|
| Up-Regulation | 3 | 2020 | 247 | 0.190 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2019 | 31 | 0.190 |
Why?
|
| Mitochondria | 1 | 2025 | 396 | 0.190 |
Why?
|
| Environmental Exposure | 2 | 2019 | 49 | 0.180 |
Why?
|
| Genotype | 2 | 2020 | 461 | 0.180 |
Why?
|
| Endothelial Cells | 1 | 2025 | 361 | 0.180 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2019 | 60 | 0.180 |
Why?
|
| Infant, Low Birth Weight | 2 | 2020 | 24 | 0.180 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 80 | 0.180 |
Why?
|
| Selenoproteins | 1 | 2020 | 1 | 0.170 |
Why?
|
| Endotoxemia | 1 | 2020 | 8 | 0.170 |
Why?
|
| Phosphorylation | 4 | 2018 | 581 | 0.170 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2021 | 31 | 0.170 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 28 | 0.170 |
Why?
|
| Oxidoreductases | 1 | 2020 | 57 | 0.170 |
Why?
|
| Gestational Age | 3 | 2020 | 146 | 0.170 |
Why?
|
| Crosses, Genetic | 1 | 2020 | 36 | 0.170 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 509 | 0.160 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 272 | 0.160 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 45 | 0.160 |
Why?
|
| Gasotransmitters | 1 | 2020 | 1 | 0.160 |
Why?
|
| Integrases | 1 | 2020 | 39 | 0.160 |
Why?
|
| Recombination, Genetic | 1 | 2020 | 64 | 0.160 |
Why?
|
| Hydrogen Sulfide | 1 | 2020 | 33 | 0.160 |
Why?
|
| Acute Disease | 1 | 2020 | 155 | 0.160 |
Why?
|
| Carbon Monoxide | 1 | 2020 | 47 | 0.160 |
Why?
|
| Kidney | 3 | 2021 | 286 | 0.160 |
Why?
|
| Premature Birth | 1 | 2020 | 57 | 0.160 |
Why?
|
| Acute Lung Injury | 2 | 2010 | 12 | 0.150 |
Why?
|
| Nitroglycerin | 1 | 2019 | 27 | 0.150 |
Why?
|
| Apolipoprotein E3 | 1 | 2019 | 12 | 0.150 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2019 | 25 | 0.150 |
Why?
|
| Memory Disorders | 1 | 2019 | 50 | 0.150 |
Why?
|
| Profilins | 1 | 2018 | 4 | 0.150 |
Why?
|
| Cofilin 1 | 1 | 2018 | 4 | 0.150 |
Why?
|
| Free Radicals | 2 | 2020 | 39 | 0.150 |
Why?
|
| Luminescence | 1 | 2018 | 8 | 0.150 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 32 | 0.150 |
Why?
|
| Transcriptome | 1 | 2020 | 214 | 0.140 |
Why?
|
| DNA | 1 | 2020 | 375 | 0.140 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 69 | 0.140 |
Why?
|
| Phosphoproteins | 1 | 2018 | 120 | 0.140 |
Why?
|
| Sheep | 4 | 2019 | 100 | 0.140 |
Why?
|
| S-Nitrosothiols | 1 | 2018 | 1 | 0.140 |
Why?
|
| Precision Medicine | 1 | 2019 | 76 | 0.140 |
Why?
|
| Serum Albumin | 1 | 2018 | 35 | 0.140 |
Why?
|
| Nitrites | 1 | 2018 | 30 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 28 | 0.130 |
Why?
|
| Hemodynamics | 1 | 2018 | 221 | 0.130 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2016 | 6 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 223 | 0.130 |
Why?
|
| Hepcidins | 1 | 2016 | 2 | 0.130 |
Why?
|
| Morphogenesis | 1 | 2016 | 22 | 0.130 |
Why?
|
| Myelin Sheath | 1 | 2016 | 28 | 0.120 |
Why?
|
| Prostaglandins | 3 | 2012 | 13 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 389 | 0.120 |
Why?
|
| Autopsy | 1 | 2015 | 26 | 0.120 |
Why?
|
| DNA Modification Methylases | 1 | 2015 | 13 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 198 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2022 | 1272 | 0.120 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 137 | 0.120 |
Why?
|
| Receptors, Notch | 1 | 2015 | 44 | 0.110 |
Why?
|
| Trachea | 2 | 2025 | 34 | 0.110 |
Why?
|
| Arginase | 1 | 2014 | 6 | 0.110 |
Why?
|
| Fetal Growth Retardation | 1 | 2014 | 32 | 0.100 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2014 | 64 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 59 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 135 | 0.100 |
Why?
|
| Child | 1 | 2019 | 2271 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 155 | 0.090 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2012 | 3 | 0.090 |
Why?
|
| Infant | 1 | 2015 | 1019 | 0.090 |
Why?
|
| Reference Standards | 1 | 2012 | 57 | 0.090 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2012 | 68 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2013 | 515 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 131 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2013 | 231 | 0.090 |
Why?
|
| Riboflavin | 1 | 2010 | 6 | 0.090 |
Why?
|
| Phagocytes | 1 | 2010 | 15 | 0.090 |
Why?
|
| Brain | 1 | 2016 | 753 | 0.080 |
Why?
|
| Cell Count | 1 | 2010 | 86 | 0.080 |
Why?
|
| Rats | 3 | 2019 | 1587 | 0.080 |
Why?
|
| Risk Factors | 3 | 2021 | 2111 | 0.080 |
Why?
|
| Obesity | 1 | 2016 | 675 | 0.080 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2010 | 28 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2010 | 59 | 0.080 |
Why?
|
| Transgenes | 1 | 2010 | 63 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 197 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 31 | 0.080 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2010 | 16 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 127 | 0.080 |
Why?
|
| Neutrophils | 1 | 2010 | 183 | 0.080 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 2020 | 35 | 0.080 |
Why?
|
| Mesenteric Arteries | 2 | 2019 | 8 | 0.070 |
Why?
|
| Myography | 2 | 2019 | 27 | 0.070 |
Why?
|
| Organ Size | 1 | 2007 | 88 | 0.070 |
Why?
|
| Age Factors | 1 | 2009 | 734 | 0.060 |
Why?
|
| Gene Expression | 2 | 2018 | 417 | 0.060 |
Why?
|
| Cell Hypoxia | 2 | 2015 | 35 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2024 | 117 | 0.050 |
Why?
|
| Smad2 Protein | 2 | 2014 | 17 | 0.050 |
Why?
|
| Dysbiosis | 1 | 2023 | 15 | 0.050 |
Why?
|
| Fibrosis | 2 | 2014 | 134 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 21 | 0.050 |
Why?
|
| Theophylline | 1 | 2021 | 6 | 0.050 |
Why?
|
| Water-Electrolyte Balance | 1 | 2021 | 6 | 0.050 |
Why?
|
| Lipocalin-2 | 1 | 2021 | 6 | 0.050 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 8 | 0.050 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2021 | 9 | 0.050 |
Why?
|
| Vulnerable Populations | 1 | 2022 | 48 | 0.040 |
Why?
|
| Caffeine | 1 | 2021 | 39 | 0.040 |
Why?
|
| Placenta | 1 | 2022 | 78 | 0.040 |
Why?
|
| Biological Products | 1 | 2022 | 66 | 0.040 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2021 | 13 | 0.040 |
Why?
|
| Research | 1 | 2021 | 93 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2021 | 181 | 0.040 |
Why?
|
| Spin Labels | 1 | 2020 | 19 | 0.040 |
Why?
|
| Cyclic N-Oxides | 1 | 2020 | 26 | 0.040 |
Why?
|
| Spleen | 1 | 2020 | 113 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2023 | 338 | 0.040 |
Why?
|
| Morbidity | 1 | 2020 | 58 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 80 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2020 | 35 | 0.040 |
Why?
|
| Arachidonate 5-Lipoxygenase | 2 | 2010 | 12 | 0.040 |
Why?
|
| Interdisciplinary Research | 1 | 2019 | 1 | 0.040 |
Why?
|
| Intersectoral Collaboration | 1 | 2019 | 7 | 0.040 |
Why?
|
| omega-N-Methylarginine | 1 | 2019 | 11 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 27 | 0.040 |
Why?
|
| Apolipoprotein E4 | 1 | 2019 | 20 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2019 | 21 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2019 | 45 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2019 | 34 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 115 | 0.040 |
Why?
|
| Arginine | 1 | 2019 | 42 | 0.040 |
Why?
|
| Adult | 2 | 2022 | 7922 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 151 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 893 | 0.040 |
Why?
|
| Machine Learning | 1 | 2019 | 91 | 0.040 |
Why?
|
| Parents | 1 | 2019 | 131 | 0.040 |
Why?
|
| Nitric Oxide Donors | 1 | 2018 | 11 | 0.040 |
Why?
|
| S-Nitrosoglutathione | 1 | 2018 | 1 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2019 | 273 | 0.040 |
Why?
|
| Biomarkers | 1 | 2021 | 770 | 0.040 |
Why?
|
| Cyclic GMP | 1 | 2018 | 29 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 554 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 56 | 0.030 |
Why?
|
| Cysteine | 1 | 2018 | 68 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 178 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 475 | 0.030 |
Why?
|
| Arteries | 1 | 2018 | 66 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1026 | 0.030 |
Why?
|
| Encephalitis | 1 | 2016 | 18 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 671 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2016 | 108 | 0.030 |
Why?
|
| Presenilin-2 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2015 | 3 | 0.030 |
Why?
|
| Presenilin-1 | 1 | 2015 | 4 | 0.030 |
Why?
|
| HMGB1 Protein | 1 | 2015 | 5 | 0.030 |
Why?
|
| Jagged-1 Protein | 1 | 2015 | 6 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2016 | 172 | 0.030 |
Why?
|
| Time Factors | 2 | 2010 | 1600 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 62 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 67 | 0.030 |
Why?
|
| Feedback | 1 | 2014 | 33 | 0.030 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2014 | 4 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2014 | 10 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 448 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2014 | 40 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 194 | 0.030 |
Why?
|
| Fetal Development | 1 | 2014 | 25 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 47 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 54 | 0.030 |
Why?
|
| Birth Weight | 1 | 2014 | 63 | 0.030 |
Why?
|
| Prostaglandin-E Synthases | 1 | 2013 | 6 | 0.030 |
Why?
|
| Lipocalins | 1 | 2013 | 3 | 0.030 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2013 | 8 | 0.030 |
Why?
|
| Adolescent | 1 | 2020 | 3165 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 26 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 232 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 79 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 130 | 0.020 |
Why?
|
| Chemokines | 1 | 2012 | 74 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 202 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 79 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 115 | 0.020 |
Why?
|
| Collagen | 1 | 2012 | 156 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2012 | 191 | 0.020 |
Why?
|
| Riboflavin Deficiency | 1 | 2010 | 2 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 409 | 0.020 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2010 | 6 | 0.020 |
Why?
|
| Coenzyme A | 1 | 2010 | 13 | 0.020 |
Why?
|
| Tyrosine | 1 | 2010 | 92 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 415 | 0.020 |
Why?
|
| Thromboxane B2 | 1 | 2009 | 2 | 0.020 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2009 | 2 | 0.020 |
Why?
|